PRA Health Sciences étend sa réponse à la COVID-19 avec des solutions de pharmacovigilance pour les traitements et vaccins autorisés

NEXT STORY
Derma Prime Plus Reviews – Negative Side Effects or Real Benefits?
PREV STORY
Inflammatory Brain Disorders Conference to be held online May 13-14, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AnaptysBio Presents Updated ANB020 and ANB019 Clinical Data at the 2018 EAACI Congress

Blood eosinophil level reduction consistent with clinical efficacy in ANB020 Phase 2a atopic dermatitis ...

author_avatar
NASDAQ Market News

Novartis drug Votubia® recommended by CHMP for EU approval to treat refractory partial-onset seizures in patients with TSC

If approved, Votubia would be the first adjunctive treatment specifically for refractory seizures in ...

author_avatar
NASDAQ Market News

MacroGenics and Zai Lab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Margetuximab, MGD013 and TRIDENT™ Molecule in Greater China

Comprehensive collaboration across three MacroGenics’ pipeline programs to accelerate and expand ongoing developmentExpand Zai ...

author_avatar
NASDAQ Market News